Frequency Therapeutics is a clinical-stage biotechnology firm that creates therapeutics to activate the body's innate regenerative abilities to restore function to damaged tissues. The company's Progenitor Cell Activation approach utilizes small molecules to activate progenitor cells within the body to produce functional tissue. It is developing medicines for patients with a variety of degenerative conditions, including multiple sclerosis, diseases of the muscles, gastrointestinal tract, skin, and bone.